btlines

MAB GPW Periodic report · PAP Biznes

Mabion SA (MAB) · Q1 2026 results

Share price: 7.84 zł · 2026-11-10

Results Q1 2026 vs Q1 2025 · year over year · published 19 May 2026 and 27 May 2025

Revenue up 51.5% year on year. The report's language is unchanged.

Only a basic analysis is available for this company at the moment.

1 · Numbers

+51.5%

Revenue vs Q1 2025

Revenue 3.8M vs 2.5M

Why Revenue rose primarily because of services performed for Novavax, Inc.

2 · How the report reads

Unchanged

Language tone vs last period

Report language: upbeat for a company report — about as upbeat as in Q1 2025.

Weak signal: formal report language, not a call.

3 · What stood out

Key theme

The company issued between 1 and 1,010,145 nominal warrants to current shareholders to facilitate an incentive program for acquiring shares.

Official channels

The company's own website and social media accounts.

Read between the lines

  1. Fading

    The company entered into contracts involving subcontractors and CDMO clients to implement the Strategy 2023-2027.

    Source quote
    “Conclusion of contracts provided by the Company in cooperation with subcontractors. Selected services will be expected and valued by CDMO clients. It is an element of the implementation of the 2023-2027 Strategy.”

Tone

How upbeat the language was, compared with other companiesiTone counts positive minus negative finance words, adjusted for length. Executives mostly speak positively, so the labels compare each call with every company's latest call: “typical” is the middle third, “very upbeat” the top tenth, “cautious” the bottom tenth.. Dot: Q1 2026. Ring: Q1 2025.

Report language Upbeat (was upbeat)

Upbeat for a company report — about as upbeat as in Q1 2025. Periodic reports carry legally required risk wording, so their tone moves little and is a weak signal.

Sentences that drove the tone
“Business development activities were intensified and it was therefore planned to significantly increase, the strategies were aimed at acquiring from 5 to 10 contracts”

Full figures

PLN · PAP Biznes report (2026-05-19)

Metric Q1 2026 Q1 2025 Change
Revenue 3.8M 2.5M +51.5%
Operating income — -14.1M
Net income — -15.3M
P/E 12-mo loss 12-mo loss —

Topics

Topics are drawn from the full report text, not management commentary.

Most discussed now

  • After analyzing the possibilities of obtaining financing (debt, equity, or mezzanine financing from investors)
  • Japan (Lender ﴿ loan agreement for the amount of 3.1 million EUR.
  • It is estimated that as a result of the planned issuance, the issue will be of a closed nature and will not be conducted in the form of a…
  • Companies and the consequences of their breach, such as an increase in the interest rate or the declaration of the entire or part of the…
  • In the period since the submission of the previous periodic report, no changes occurred in the status of possession in terms of, among…

Faded since Q1 2025

  • Dropped Taking the above into account, in the case of downtime or failure to provide services, a premium due to the title holder should be expected.
  • Dropped Financial costs consist mainly of the held fixed assets, the value of which may require adjustment due to negative exchange rate…
  • Dropped The main objective of the project, which the Company saw as an opportunity to realize, was to increase R&D activity through the…
  • Dropped In the reported reporting period, the Company recognized and presented the cost of sales at the aggregating level > depreciation of…

Latest announcements

Official filings, newest first.

Similar companies

Healthcare · Biotechnology
All Healthcare companies →